Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding

AVITA Medical (RCEL) Shares Issued (2020 - 2025)

AVITA Medical filings provide 6 years of Shares Issued readings, the most recent being $14.4 million for Q4 2025.

On a quarterly basis, Shares Issued rose 3214.75% to $14.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $14.8 million, a 592.83% increase, with the full-year FY2025 number at $14.8 million, up 592.83% from a year prior.
Shares Issued hit $14.4 million in Q4 2025 for AVITA Medical, up from $32000.0 in the prior quarter.
In the past five years, Shares Issued ranged from a high of $14.4 million in Q4 2025 to a low of -$81.6 million in Q2 2021.
Median Shares Issued over the past 5 years was $117000.0 (2023), compared with a mean of -$7.3 million.
The widest YoY moves for Shares Issued: up 17000.0% in 2023, down 98.33% in 2023.
AVITA Medical's Shares Issued stood at $3000.0 in 2021, then skyrocketed by 29866.67% to $899000.0 in 2022, then tumbled by 98.33% to $15000.0 in 2023, then soared by 2793.33% to $434000.0 in 2024, then skyrocketed by 3214.75% to $14.4 million in 2025.
The last three reported values for Shares Issued were $14.4 million (Q4 2025), $32000.0 (Q3 2025), and $11000.0 (Q2 2025) per Business Quant data.